Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells

Journal of Asian Natural Products Research

Volumn 5, Issue 2, 2003, Pages 151-157

  Shen, Fang ^a   Chen, Su Juan ^b   Dong, Xiao Jun ^b   Zhong, Hui ^b   Li, Yi Tang ^a   Cheng, Gui Fang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

AP 1; IL 8; NF B; Resveratrol; U937

Indexed keywords

GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PHORBOL ESTER; RESVERATROL; TRANSCRIPTION FACTOR AP 1;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DNA BINDING; DRUG MECHANISM; ELECTROPHORETIC MOBILITY; GRAPE; HUMAN; HUMAN CELL; MONOCYTE; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DEXAMETHASONE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; INTERLEUKIN-8; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; U937 CELLS;

VITACEAE; VITIS SP.;

EID: 0038367663     PISSN: 10286020     EISSN: None     Source Type: Journal    
DOI: 10.1080/1028602031000066852     Document Type: Article

References (18)

1. Gusman, J., Malonne, H. and Atassi, G. (2001), Carcinogenesis 22, 1111-1117.
2. Bhat, K.P.L., Kosmeder, J.W. and Pezzuto, J.M. (2001), Antioxid. Redox Signal. 3, 1041-1064.
3. Mukaida, N., Harada, A. and Matsushima, K. (1998), Cytokine Growth Factor Rev. 9,9-23.
4. Rot, A., Hub, E., Middleton, J., Pons, F., Rabeck, C., Thierer, K., Wintle, J., Wolff, B., Zsak, M. and Dukor, P. (1996), J. Leukoc. Biol. 59, 39-44.
5. Harada, A., Sekido, N., Akahoshi, T., Wada, T., Mukaida, N. and Matsushima, K. (1994), J. Leukoc. Biol. 56, 559-564.
6. Na, Y.J., Jeon, Y.J., Suh, J.H., Kang, J.S., Yang, K.H. and Kim, H.M. (2001), Int. Immunopharmacol. 1, 1877-1887.
7. Sasakawa, Y., Sakuma, S., Higashi, Y., Sasakawa, T., Amaya, T. and Goto, T. (2000), Eur. J. Pharmacol. 403, 281-288.
8. Kurtz, R.M., Elner, V.M., Bian, Z.M., Strieter, R.M., Kunkel, S.L. and Elner, S.G. (1997), Investig. Ophthalmol. Vis. Sci. 38, 436-445.
9. Brakenhielm, E., Cao, R. and Cao, Y. (2001), FASEB J. 15, 1798-1800.
10. Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W., Fong, H.H., Farnsworth, N.R., Kinghom, A.D., Mehta, R.G., Moon, R.C. and Pezzuto, J.M. (1997), Science 275, 218-220.
11. Tsai, S.H., Lin-Shiau, S.Y. and Lin, J.K. (1999), Br. J. Pharmacol. 126, 673-680.
12. Subbaramaiah, K., Michaluart, P., Chung, W.J., Tanabe, T., Telang, N. and Dannenberg, A.J. (1999), Ann. N.Y. Acad. Sci. 889, 214-223.
13. Surh, Y.J., Hurh, Y.J., Kang, J.Y., Lee, E., Kong, G. and Lee, S.J. (1999), Cancer Lett. 140, 1-10.
14. Waffo-Teguo, P., Hawthorne, M.E., Cuendet, M., Merillon, J.M., Kinghom, A.D., Pezzuto, J.M. and Mehta, R.G. (2001), Nutr. Cancer 40, 173-179.
15. Zhong, M., Cheng, G.F., Wang, W.J., Guo, Y., Zhu, X.Y. and Zhang, J.T. (1999), Phytomedicine 6, 79-84.
16. Holmes-McNary, M. and Baldwin, Jr., A.S. (2000), Cancer Res. 60, 3477-3483.
17. Li, L.C., Shen, F., Hou, Q. and Cheng, G.F. (2001), Acta Pharm. Sin. 23, 138-142.
18. Guo, Y., Hu, Y.F. and Cheng, G.F. (1999), Acta Pharm. Sin. 34, 586-589.